For the quarter ending 2026-03-31, CCAP had -$4,904K decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net increase (decrease) in net assets resulting from operations | -15,513 | 8,490 | 7,102 | 18,917 |
| Purchases of investments | 114,895 | 70,794 | 73,906 | 162,181 |
| Paid-in-kind interest income | 1,783 | 2,412 | 2,917 | 5,280 |
| Increase (decrease) in incentive fees payable | - | - | - | -748 |
| Proceeds from sales of investments and principal repayments | 93,100 | 78,152 | 85,999 | 170,684 |
| Net realized (gain) loss on investments and foreign currency transactions | -11,603 | 3,442 | -5,144 | -8,898 |
| Net change in unrealized (appreciation) depreciation on investments and foreign currency translation | -19,327 | -11,347 | -5,790 | 790 |
| Net change in unrealized (appreciation) depreciation on foreign currency forward contracts | -75 | 191 | 972 | -5,977 |
| Amortization of premium and accretion of discount, net | -1,461 | -1,356 | -1,354 | -4,157 |
| Amortization of deferred financing costs | 611 | 607 | 607 | 2,224 |
| (increase) decrease in receivable for unsettled transactions | 4,458 | 2,734 | -9,077 | 13,199 |
| (increase) decrease in interest and dividend receivable | 1,611 | -599 | 2 | -1,078 |
| (increase) decrease in deferred tax asset | 45 | 9 | -42 | -523 |
| (increase) decrease in other assets | 1,586 | -124 | 14 | 1,390 |
| Increase (decrease) in management fees payable | -122 | -82 | 44 | 9 |
| Increase (decrease) in incentive fees payable | -1,893 | -106 | -731 | - |
| Increase (decrease) in interest and other debt financing costs payable | -4,017 | 4,427 | -4,536 | 2,071 |
| Increase (decrease) in deferred tax liability | 45 | 9 | -42 | -523 |
| Increase (decrease) in payable for investment purchased | - | 0 | - | - |
| Increase (decrease) in accrued expenses and other liabilities | -1,175 | 17 | 689 | -805 |
| Net cash provided by (used for) operating activities | -23,798 | 22,646 | 30,768 | 21,308 |
| Issuance of unsecured debt | 135,000 | 0 | 0 | 115,000 |
| Repayment of unsecured debt | 135,000 | - | - | - |
| Repurchases of common stock | 1,000 | 1,000 | 333 | - |
| Deferred financing and debt issuance costs paid | 1,479 | 0 | 0 | 1,065 |
| Distributions paid | 15,527 | 15,565 | 17,410 | 34,838 |
| Borrowings on credit facilities | 214,141 | 104,429 | 81,642 | 211,367 |
| Repayments on credit facilities | 177,385 | 106,772 | 92,950 | 325,041 |
| Net cash provided by (used for) financing activities | 18,750 | -18,908 | -29,051 | -34,577 |
| Effect of exchange rate changes on cash denominated in foreign currency | 144 | -44 | -54 | -13 |
| Net increase (decrease) in cash, cash equivalents, restricted cash and foreign currency | -4,904 | 3,694 | 1,663 | -13,282 |
| Cash, cash equivalents, restricted cash and foreign currency, beginning of period | 31,497 | 27,803 | 39,422 | - |
| Cash, cash equivalents, restricted cash and foreign currency, end of period | 26,593 | 31,497 | 27,803 | - |
Crescent Capital BDC, Inc. (CCAP)
Crescent Capital BDC, Inc. (CCAP)